Technical Analysis for BAX - Baxter International Inc.

Grade Last Price % Change Price Change
grade A 76.95 0.01% 0.01
BAX closed up 0.01 percent on Monday, March 18, 2019, on 60 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical BAX trend table...

Date Alert Name Type % Chg
Mar 18 MACD Bullish Signal Line Cross Bullish 0.00%
Mar 18 Cup with Handle Other 0.00%
Mar 18 Bollinger Band Squeeze Range Contraction 0.00%
Mar 18 NR7 Range Contraction 0.00%
Mar 18 Upper Bollinger Band Walk Strength 0.00%
Mar 18 BB Squeeze + Upper Band Touch Range Contraction 0.00%
Mar 18 Overbought Stochastic Strength 0.00%
Mar 18 Up 3 Days in a Row Strength 0.00%
Mar 18 Up 4 Days in a Row Strength 0.00%
Mar 18 Up 5 Days in a Row Strength 0.00%

Older signals for BAX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates in two segments, BioScience and Medical Products. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and certain vaccines. The Medical Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. It also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies; and to treat end-stage renal disease or irreversible kidney failure. In addition, this segment manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes products for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. serves hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, clinical and medical research laboratories, and patients at home under physician supervision in the United States, Europe, the Asia-Pacific, Latin America, and Canada. The company sells its products through its direct sales force, as well as to and through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. Baxter International Inc. was founded in 1931 and is based in Deerfield, Illinois.
Medicine Alpha Infectious Diseases Disorders Dialysis Membrane Technology End Stage Renal Disease Hemodialysis Nutrition Products Hemophilia Renal Dialysis Kidney Burns Kidney Dialysis Kidney Disease Antitrypsin Deficiency Nephrology Drug Wholesalers Immune Disorders Kidney Failure Peritoneal Dialysis Alpha 1 Antitrypsin Biosurgery Products Shock
Is BAX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 78.38
52 Week Low 61.05
Average Volume 3,080,218
200-Day Moving Average 71.3407
50-Day Moving Average 72.073
20-Day Moving Average 75.1995
10-Day Moving Average 75.687
Average True Range 0.9625
ADX 38.65
+DI 34.416
-DI 14.0153
Chandelier Exit (Long, 3 ATRs ) 74.2525
Chandelier Exit (Short, 3 ATRs ) 75.2675
Upper Bollinger Band 77.099
Lower Bollinger Band 73.3
Percent B (%b) 0.96
BandWidth 5.051895
MACD Line 1.2644
MACD Signal Line 1.256
MACD Histogram 0.0084
Fundamentals Value
Market Cap 41.93 Billion
Num Shares 545 Million
EPS 1.65
Price-to-Earnings (P/E) Ratio 46.64
Price-to-Sales 3.44
Price-to-Book 3.85
PEG Ratio 2.01
Dividend 0.64
Dividend Yield 0.83%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 77.91
Resistance 3 (R3) 77.87 77.50 77.75
Resistance 2 (R2) 77.50 77.26 77.53 77.70
Resistance 1 (R1) 77.23 77.11 77.05 77.27 77.64
Pivot Point 76.86 76.86 76.77 76.89 76.86
Support 1 (S1) 76.59 76.62 76.41 76.63 76.26
Support 2 (S2) 76.22 76.47 76.25 76.20
Support 3 (S3) 75.95 76.22 76.15
Support 4 (S4) 75.99